- https://doi.org/10.1016/j.jval.2024.10.1575
HPR149 An Update on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reimbursed Under a Managed Access Protocol in Ireland
- Dec 1, 2024
- Value in Health
- S Browne +5 more
Abstract
HPR149 An Update on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reimbursed Under a Managed Access Protocol in Ireland